# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107284
Filing Date
2025-08-12
Accepted
2025-08-12 16:05:21
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vivs-20250630.htm iXBRL | 10-Q | 1709082
2 | EX-31.1 | vivs-ex31_1.htm | EX-31.1 | 13842
3 | EX-31.2 | vivs-ex31_2.htm | EX-31.2 | 13810
4 | EX-32.1 | vivs-ex32_1.htm | EX-32.1 | 11462
| Complete submission text file | 0000950170-25-107284.txt |  | 7013206

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | vivs-20250630.xsd | EX-101.SCH | 1165693
62 | EXTRACTED XBRL INSTANCE DOCUMENT | vivs-20250630_htm.xml | XML | 954162

Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 251206600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)